Top Angio Suites Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Angio Suites Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Angio Suites industry players.

Angio Suites Market Competitive Landscape

The competitive landscape of the Angio Suites market is shaped by rapid technological innovation and strategic consolidation. Siemens Healthineers, GE Healthcare, Philips, Canon Medical, and Shimadzu dominate the U.S. market, with Siemens strengthening its lead through the launch of its ARTIS icono biplane system in March 2023. It is designed for high-precision 3D imaging in neurovascular and cardiac procedures. This move responds to the global surge in demand for minimally invasive, image-guided interventions, particularly in stroke and structural heart disease treatment.

Meanwhile, GE Healthcare reinforced its position through the USD 1.45 billion acquisition of BK Medical in 2023, enabling it to integrate real-time intraoperative imaging with its existing systems. This reflects a broader industry shift toward hybrid operating rooms and all-in-one imaging platforms. Philips, Canon Medical, and Shimadzu continue to compete through innovation in detector technology and workflow automation, with Canon focusing on AI-based imaging enhancements. The market remains highly dynamic, with product differentiation and cross-modality integration key to competitive advantage.

Top Player’s Company Profiles

  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • Hitachi, Ltd.
  • Carestream Health, Inc.
  • Hologic, Inc.
  • Samsung Healthcare
  • Allengers Medical Systems Ltd.
  • FUJIFILM Holdings Corporation
  • ZEISS International
  • Surgical Science
  • Philips Healthcare Informatics Inc
  • ESAOTE SPA
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • PLANMED OY
  • IMRIS
  • 3D Systems, Inc.
  • Prima Care Vascular Center

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Angio Suites Market size was valued at USD 2.43 Billion in 2024 and is poised to grow from USD 2.56 Billion in 2025 to USD 3.97 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026–2033).

The competitive landscape of the Angio Suites market is shaped by rapid technological innovation and strategic consolidation. Siemens Healthineers, GE Healthcare, Philips, Canon Medical, and Shimadzu dominate the U.S. market, with Siemens strengthening its lead through the launch of its ARTIS icono biplane system in March 2023. It is designed for high-precision 3D imaging in neurovascular and cardiac procedures. This move responds to the global surge in demand for minimally invasive, image-guided interventions, particularly in stroke and structural heart disease treatment. 'Siemens Healthineers AG', 'GE HealthCare Technologies Inc.', 'Koninklijke Philips N.V.', 'Canon Medical Systems Corporation', 'Shimadzu Corporation', 'Hitachi, Ltd.', 'Carestream Health, Inc.', 'Hologic, Inc.', 'Samsung Healthcare', 'Allengers Medical Systems Ltd.', 'FUJIFILM Holdings Corporation', 'ZEISS International', 'Surgical Science', 'Philips Healthcare Informatics Inc', 'ESAOTE SPA', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd.', 'PLANMED OY', 'IMRIS', '3D Systems, Inc.', 'Prima Care Vascular Center'

Increasing numbers of patients around the world are focusing on opting for personalized healthcare analytics solutions that fit their lifestyles to improve their chances of better treatment. Digital health applications, fitness trackers, and AI-driven health recommendations empower individuals to take charge of their health and wellness whilst getting them personalized healthcare as per their expectations.

North America leads the global angio suites market, contributing 38% of the total market share in 2024. This dominance is driven by a high prevalence of cardiovascular diseases (CVDs), with approximately 20.5 million Americans affected by coronary artery disease (CAD) and around 805,000 experiencing myocardial infarctions annually. The region's advanced healthcare infrastructure, significant investments in medical technology, and early adoption of AI-integrated diagnostic tools further bolster market growth

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Angio Suites Market
Angio Suites Market

Report ID: SQMIG35G2319

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE